Trial intelligence / Profile preview

OM-85 for prevention of asthma exacerbations in adolescents and adults with moderate to severe asthma

NL-OMON43072Active, not recruiting

Sponsor
Investigator initiated trial by clinical researchers of the Department of Pediatrics and Department of Pulmonology; Franciscus Gasthuis & Vlietland, Rotterdam
Start
Oct 2016
Modality
Whole Cell Cancer Vaccines → Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
Countries
1
01

Overview

Randomised, double-blind trial in asthma comparing Broncho-Vaxom with Placebo (2 arms). Primary endpoint: Total number of asthma exacerbations within 18 months after initiation of intervention. Started Oct 2016; status: active, not recruiting.

02

Drugs

OM-85
03

Conditions

asthma

Beyond the preview

Go deeper on NL-OMON43072.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON43072.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call